Hysbysiad contract
Adran I:
Endid
contractio
I.1) Enw a chyfeiriad
Genomics England Ltd
Dawson Hall, Charterhouse Square
London
EC1M 6BQ
UK
Person cyswllt: Paul Nicholson, Procurement Lead
Ffôn: +44 2078825030
E-bost: paul.nicholson@genomicsengland.co.uk
NUTS: UKI
Cyfeiriad(au) rhyngrwyd
Prif gyfeiriad: https://www.genomicsengland.co.uk
I.3) Cyfathrebu
Mae'r dogfennau caffael ar gael ar gyfer mynediad uniongyrchol anghyfyngedig a llawn, yn rhad ac am ddim ar:
https://genomicsengland.bravosolution.co.uk/genomicsengland/web/login.html
Gellir cael gwybodaeth ychwanegol o'r cyfeiriad uchod
Rhaid anfon tendrau neu geisiadau i gymryd rhan yn electronig at:
https://genomicsengland.bravosolution.co.uk/genomicsengland/web/login.html
Rhaid anfon tendrau neu geisiadau i gymryd rhan i'r cyfeiriad uchod:
I.4) Y math o awdurdod contractio
Corff a lywodraethir gan gyfraith gyhoeddus
I.5) Prif weithgaredd
Arall: Genomics
Adran II: Gwrthrych
II.1) Cwmpas y caffaeliad
II.1.1) Teitl
Research Environment Clinical Data Platform
Cyfeirnod: GeL-RE-004-18
II.1.2) Prif god CPV
72222300
II.1.3) Y math o gontract
Gwasanaethau
II.1.4) Disgrifiad byr
As part of 100 000 Genome Project, Genomics England established a secure Research Environment (RE) to contribute to the realisation of Genomics England’s target benefits which are:
— patient benefit,
— new scientific insights and discovery,
— accelerating the uptake of genomic medicine in the NHS,
— stimulating and enhancing UK industry and investment, and
— increasing public knowledge and support for genomic medicine.
Design, development and operation of the RE are driven by its objective to “provide a secure and collaborative workspace that enables researchers and industry to perform genomic data analysis to accelerate scientific discovery.”
II.1.6) Gwybodaeth am lotiau
Mae’r contract hwn wedi’i rannu’n lotiau:
Na
II.2) Disgrifiad
II.2.2) Cod(au) CPV ychwanegol
48000000
48100000
71600000
71621000
72000000
72212100
72262000
II.2.3) Man cyflawni
Cod NUTS:
UKI
Prif safle neu fan cyflawni:
London
II.2.4) Disgrifiad o’r caffaeliad
As part of 100 000 Genome Project, Genomics England established a secure Research Environment (RE) to contribute to the realisation of Genomics England’s target benefits which are:
— patient benefit,
— new scientific insights and discovery,
— accelerating the uptake of genomic medicine in the NHS,
— stimulating and enhancing UK industry and investment, and
— increasing public knowledge and support for genomic medicine.
Design, development and operation of the RE are driven by its objective to “provide a secure and collaborative workspace that enables researchers and industry to perform genomic data analysis to accelerate scientific discovery.”
Below outlines the scope of the RE and the target capabilities that are being delivered as part of a programme of work. A brief description of the capabilities that are to be delivered are provided below.
People
— staff appropriately skilled to implement, maintain and support the required data platforms,
— recruitment and staff development that maintains the required skills within Genomics England,
— organisational structures and resources required to support the effective operation and improvement of the data platforms.
Policy and Process
— solutions that drive a standardised approach to data governance, consent practises, data release and other relevant policies and processes,
— solutions that enable effective management of data quality,
— policies and processes that enable users to work securely, efficiently and effectively in the Research Environment.
Technology
— software and infrastructure that meet functional, security, governance, capacity and performance requirements of the research environment,
— technology providing the usability, availability, accessibility, flexibility, interoperability and scalability required by both academic and commercial users.
A key component of the RE is a clinical data platform. The platform will accommodate unstructured, semi-structured and structured data.
Over and above the platform, there is a requirement for support services.
II.2.5) Meini prawf dyfarnu
Nid pris yw’r unig faen prawf dyfarnu a dim ond yn y dogfennau caffael y mae’r holl feini prawf wedi’u nodi
II.2.7) Hyd y contract, y cytundeb fframwaith neu’r system brynu ddynamig
Hyd mewn misoedd: 60
Gall y contract hwn gael ei adnewyddu: Ydy
Disgrifiad o’r adnewyddiadau:
Initial contract length of 36 months with 2 options to renew for 12 month periods making the total possible contract length 60 months.
II.2.9) Gwybodaeth am y cyfyngiadau ar nifer yr ymgeiswyr a gaiff eu gwahodd
II.2.10) Gwybodaeth am amrywiadau
Derbynnir amrywiadau:
Na
II.2.11) Gwybodaeth am opsiynau
Opsiynau:
Na
II.2.13) Gwybodaeth am Gronfeydd yr Undeb Ewropeaidd
Mae'r broses gaffael yn gysylltiedig â phrosiect a/neu raglen a ariennir gan gronfeydd yr Undeb Ewropeaidd:
Na
Section III: Gwybodaeth gyfreithiol, economaidd, ariannol a thechnegol
III.1) Amodau ar gyfer cymryd rhan
III.1.2) Statws economaidd ac ariannol
Meini prawf dethol fel y’u nodir yn y dogfennau caffael
III.1.3) Gallu technegol a phroffesiynol
Meini prawf dethol fel y’u nodir yn y dogfennau caffael
III.2) Amodau sy’n gysylltiedig â’r contract
Section IV: Gweithdrefn
IV.1) Disgrifiad
IV.1.1) Y math o weithdrefn
Gweithdrefn gyfyngedig
IV.1.8) Gwybodaeth am Gytundeb Caffael y Llywodraeth (GPA)
The procurement is covered by the Government Procurement Agreement:
Na
IV.2) Gwybodaeth weinyddol
IV.2.1) Cyhoeddiad blaenorol mewn perthynas â’r weithdrefn hon
Rhif yr hysbysiad yn OJ S:
2018/S 207-472572
IV.2.2) Terfyn amser i dendrau neu geisiadau i gymryd rhan ddod i law
Dyddiad:
24/05/2019
Amser lleol: 12:00
IV.2.3) Dyddiad amcangyfrifedig ar gyfer anfon gwahoddiadau i dendro neu i gymryd rhan at yr ymgeiswyr a ddewiswyd
Dyddiad:
07/06/2019
IV.2.4) Ym mha iaith/ieithoedd y gellir cyflwyno tendrau neu geisiadau i gymryd rhan
EN
IV.2.6) Yr isafswm cyfnod gofynnol i’r sawl sy’n tendro gynnal y tendr
Hyd mewn misoedd: 3 (o’r dyddiad a nodwyd i dendr ddod i law)
Section VI: Gwybodaeth ategol
VI.1) Gwybodaeth am ailddigwydd
Caffaeliad cylchol yw hwn:
Na
VI.2) Gwybodaeth am lifau gwaith electronig
Derbynnir anfonebau electronig
Defnyddir taliadau electronig
VI.3) Gwybodaeth ychwanegol
The Contracting Authority expressly reserves the right
(i) not to award any contract as a result of the procurement process commenced by publication of this notice; and
(ii) to make whatever changes it may see fit to the content and structure of the tendering competition; and in no circumstances will the Contracting Authority be liable for any costs incurred by the candidates. Any expenditure, work or effort undertaken prior to contract award is accordingly a matter solely for the commercial judgement of potential suppliers.
(a) Genomics England reserves the right at any stage to reject or disqualify or revise the pre-qualified status of any tenderer who:
1) Provides information or confirmations which later prove to be untrue or incorrect; and/or
2) Does not submit a tender in accordance with the requirements of the tender document or as otherwise directed by Genomics England during the procurement process; and/or
3) Fulfils any one or more of the criteria detailed in the Public Contracts Regulations 2016 pertaining to Mandatory Exclusions.
(b) further information on Genomics England may be found at https://www.genomicsengland.co.uk/
(c) all discussions and meetings will be conducted in English;
(d) tenders and supporting documents must be priced in GBP and all payments under the contract will be made in sterling;
(e) Genomics England may interview any or all economic operators who express an interest in tendering for this work.
VI.4) Gweithdrefnau adolygu
VI.5) Dyddiad anfon yr hysbysiad hwn
17/04/2019